Journal of SAFOMS

Register      Login

VOLUME 2 , ISSUE 1 ( January-June, 2014 ) > List of Articles


Topical Nitroglycerin: A New and Safe Treatment Option for Osteoporosis

Ayush Agarwal, Omkar Singh, Prabhat Agrawal

Citation Information : Agarwal A, Singh O, Agrawal P. Topical Nitroglycerin: A New and Safe Treatment Option for Osteoporosis. J South Asian Feder Menopause Soc 2014; 2 (1):20-22.

DOI: 10.5005/jp-journals-10032-1027

Published Online: 01-08-2014

Copyright Statement:  Copyright © 2014; The Author(s).


PDF Share
  1. Applied therapeutics: the clinical use of drugs. Philadelphia: Wolters Kluwer Health/Lippincott Williams and Wilkins. 2009. p. 101-103.
  2. Preventive Services Task, Force (Feb 26, 2013). Vitamin D and Calcium Supplementation to Prevent Fractures in Adults: US Preventive Services Task Force Recommendation Statement. Annals of Internal Medicine 2013;158:691-696.
  3. Osteopaenia in primary healthcare patients: do we need to be more rigorous? Rheumatol Clin 2009;5(1):13-17.
  4. The effects of organic nitrates on osteoporosis: a randomized control trial [ISRCTN94484747]. Trials 2006;7:10.
  5. Osteoporosis-an emerging disease of the 21st century, part 1: An overview. Jfmpc 2012;1(1):66-68.
  6. Rationale for using nitric oxide donor therapy for prevention of bone loss and treatment of osteoporosis in humans. Ann NY Acad Sci 2007 Nov;1117:283-297.
  7. Effect of nitric oxide donor nitroglycerin on bone mineral density in a rat model of estrogen deficiency-induced osteopenia. Bone 2003;32:142-149.
  8. The effects of organic nitrates on osteoporosis: a systematic review. Osteoporos Int 2013 Mar; 24(3):763-770.
  9. Nitric oxide novel therapy for osteoporosis. Expert Opin Pharmacother 2008 Dec;9(17):3025-3044.
  10. Decreased fracture risk in users of organic nitrates: a nationwide case-control study. J Bone Miner Res 2006;21(11):1811-1817.
  11. Nitric oxide synthase: models and mechanisms. Current Opinion in Chemical Biology 2000 Dec;4(6):687-695.
  12. Nitroglycerin therapy is as efficacious as standard estrogen replacement therapy (Premarin) in prevention of oophorectomy-induced bone loss; a human pilot clinical study. J Bone Miner Res 2000 Nov;15(11):2240-2244.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.